Valuation: H&R GmbH & Co. KGaA

Market Cap 238M 271M 222M 203M 382M 26.12B 388M 2.63B 1.03B 12.84B 1.02B 996M 44.4B P/E 2026 *
7.22x
P/E 2027 * 21.4x
Enterprise Value 261M 297M 243M 223M 419M 28.63B 425M 2.88B 1.13B 14.07B 1.12B 1.09B 48.66B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
21.97%
Yield 2026 *
0.78%
Yield 2027 * 0.78%
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
25-03-26 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day-2.14%
1 week-0.62%
Current month+28.77%
1 month+31.42%
3 months+39.13%
6 months+47.13%
Current year+49.18%
1 week 6.08
Extreme 6.08
6.68
1 month 4.51
Extreme 4.51
6.68
Current year 3.91
Extreme 3.91
6.68
1 year 3.91
Extreme 3.91
6.68
3 years 3.23
Extreme 3.23
6.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-0.62%+28.51%+23.55% 277M
+0.54%+0.03%+12.30%+32.85% 127B
-9.90%-10.80%+447.84%+153.57% 48.25B
-0.84%+0.95%-2.58%-37.91% 42.27B
-2.30%+5.30%+17.98%-19.84% 34.89B
-3.75%+9.77%+44.59%+74.61% 26.08B
-2.27%+1.94%-0.63%-33.58% 19.92B
-2.76%+12.64%+62.06%+240.10% 18.4B
-0.68%+0.15%+25.37%+391.29% 17.4B
-5.78%+4.28%+290.86%+526.84% 17.62B
Average -2.99%+1.55%+92.63%+135.15% 35.18B
Weighted average by Cap. -2.37%+0.63%+89.68%+88.30%

Financials

2026 *2027 *
Net sales 1.33B 1.51B 1.24B 1.14B 2.13B 146B 2.17B 14.69B 5.74B 71.72B 5.69B 5.56B 248B 1.33B 1.52B 1.24B 1.14B 2.14B 146B 2.17B 14.72B 5.75B 71.84B 5.7B 5.57B 248B
Net income 9.3M 10.59M 8.65M 7.94M 14.91M 1.02B 15.14M 103M 40.12M 501M 39.75M 38.89M 1.73B 11.3M 12.87M 10.51M 9.64M 18.12M 1.24B 18.4M 125M 48.75M 609M 48.3M 47.26M 2.11B
Net Debt 22.87M 26.04M 21.27M 19.51M 36.67M 2.51B 37.23M 253M 98.66M 1.23B 97.74M 95.63M 4.26B 8.65M 9.85M 8.05M 7.38M 13.87M 949M 14.08M 95.53M 37.32M 466M 36.97M 36.18M 1.61B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change Volume
26-07-24 €6.400 -2.14% 12,518
26-07-23 €6.540 +1.87% 19,390
26-07-22 €6.420 -0.93% 6,110
26-07-21 €6.480 +1.57% 31,979
26-07-20 €6.380 -0.93% 20,209
Trader
Investor
Global
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.400EUR
Average target price
6.250EUR
Spread / Average Target
-2.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock